Close menu




August 22nd, 2025 | 07:10 CEST

Gold story remains intact – Three good ideas for every portfolio: Dryden Gold, Kinross Gold, and Barrick Mining

  • Mining
  • Gold
  • Investments
Photo credits: pexels

"Gold is money. Everything else is credit" – banker JP Morgan recognized this long ago. The precious metal is currently in high demand again. ETF investors in particular, but also central banks, are betting on gold. In July, global holdings in ETFs climbed to 3,639 tons, the highest level since August 2022. Central banks have purchased around 1,000 tons of gold annually over the past three years – about twice the amount they bought per year in the previous decade. This shows that demand from both private and professional investors remains unbroken. We present three promising gold stocks and explain where even speculative investors can get their money's worth.

time to read: 3 minutes | Author: Nico Popp
ISIN: DRYDEN GOLD CORP | CA26245V1013 , KINROSS GOLD CORP. | CA4969024047 , BARRICK MINING CORPORATION | CA06849F1080

Table of contents:


    Barrick: Gold price drives growth

    The combination of inflation fears, currency concerns and war has driven gold to new highs this year, with the gold price reaching an all-time high of around USD 3,500 per ounce. That is almost 95% more than at the start of the war in Ukraine in February 2022. HSBC analysts have revised their forecast for the gold price upwards and also see the risk of further rising government debt as supporting the precious metal. Investors looking to invest in gold have several options: Physical investments are the classic choice and are suitable as crisis insurance and a reserve asset. ETFs offer the opportunity to take tactical positions, but excess returns are not possible. Gold stocks, on the other hand, offer very different risk/reward profiles. Barrick Mining is considered the world's second-largest gold producer.

    According to the Reuters news agency, Barrick posted strong results in the second quarter despite a slight decline in production. At 797,000 ounces, gold production was below the previous year's figure of 948,000 ounces, but the high gold price boosted revenue significantly. The adjusted net profit was USD 0.47 per share, exceeding analysts' expectations by 2 cents. Barrick Mining increased its cash flow in the first half of the year by 32% compared to the same period last year and generated free cash flow of a whopping USD 770 million. Here, too, the Company is benefiting from the high gold price. Barrick's stock is increasingly seen as a conservative alternative, as its balance sheet is solid and the Company is returning capital to investors through share buybacks. However, Barrick Mining is unlikely to generate significant excess returns compared to the gold price.

    Kinross Gold: A good second-tier alternative

    The situation looks somewhat better for mid-sized producers such as Kinross Gold. Kinross produces between 2 and 2.5 million ounces of gold annually. Key assets in its portfolio include Paracatu in Brazil, Fort Knox and Round Mountain in the US, as well as the Tasiast mine in Mauritania. The latter has recently been expanded and is now considered one of Kinross' most cost-efficient mines. The Company is trying to continuously find new resources on its projects in order to increase its overall value. Although its regional focus is diversified, it still maintains a focus on secure legal jurisdictions. This summer alone, several analysts issued "Buy" recommendations for the stock, including UBS and National Bank Financial. The stock has the potential to outperform the gold price, though with a market capitalization of around USD 20 billion**, the potential remains somewhat limited.

    Dryden Gold: Bonanza grades and plenty of upside

    The Dryden Gold share is in a completely different league. Dryden does not have any active gold mines, but is advancing promising properties. The Company focuses on projects in the northwestern Ontario district of Canada, particularly historic gold mines in the Dryden Belt that have not yet been explored using modern methods. What makes companies like Dryden special is that they are traded at a significant discount because potential production is still a long way off. Dryden's shares are therefore currently valued at only around EUR 20 million. Nevertheless, there are already initial indications of the potential of Dryden Gold's projects: The team discovered several high-grade ore trends near the town of Dryden. The Elora Jubilee System in particular yielded bonanza grades of 301.7 g/t gold over a distance of 3.9 m. The Company also encountered gold in neighboring zones, some of which is visible to the naked eye. Further drill results are currently pending. If Dryden Gold succeeds in identifying contiguous gold zones, the Company could become the focus of producers looking to acquire assets in safe jurisdictions. Dryden Gold is already well known within the industry. Mid-sized producer Centerra Gold has already taken the plunge and secured a 9.9% stake in Dryden.

    Analysts optimistic – Gold stocks for every type of investor

    Analysts also find the stock interesting: Research firm Couloir Capital set a price target of CAD 0.65 in June, representing more than 100% upside potential based on the current price. While progress at gold producers tends to be announced gradually and valuation adjustments are also slow, things can move quickly for project developers such as Dryden Goldafter the drilling results in June, the share price jumped by more than 50%. While conservative investors are well served by stocks such as Barrick Mining or Kinross Gold, those looking to add some spice to their portfolio should also consider stocks like Dryden Gold. Moderately allocated**, these stocks are even suitable for investors with a conservative risk profile.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by André Will-Laudien on June 29th, 2026 | 07:30 CEST

    AI and M&A Frenzy in the Life Sciences Sector: Bayer, Vidac Pharma, Novo Nordisk, Evotec, and Eli Lilly

    • Biotechnology
    • Pharma
    • Biotech
    • AI
    • Investments

    Yes, you read that correctly. Pharmaceutical companies are actively embracing artificial intelligence (AI) and, thanks to lower costs, better validation, and faster study setups, could emerge as winners of the new AI wave in the medium term. Many stocks in the life sciences sector had been overlooked by the market, but investors are now taking notice again. Eli Lilly is betting on AI and expanding its portfolio through targeted acquisitions, including the takeovers of sleep-wake specialist Centessa Pharmaceuticals and blood cancer specialist Ajax. At Evotec and Vidac Pharma, much of the focus is on cancer, while Novo Nordisk faces stiff competition from Eli Lilly's weight-loss drugs. Then came the welcome news regarding Bayer. The Supreme Court ruled that approximately 181,000 individual lawsuits alleging a lack of warning labels on packaging are no longer legally viable, as the US Environmental Protection Agency (EPA) has classified the herbicide glyphosate as safe. Lots of good news, and plenty of opportunities for active investors - we provide a few insights.

    Read

    Commented by Fabian Lorenz on June 29th, 2026 | 07:15 CEST

    Gold at USD 6,000! Analysts Turn Bullish! Lahontan Gold Stock Belongs in the Portfolio

    • Mining
    • Gold
    • Silver
    • Commodities
    • Nevada
    • geopolitics

    Will the falling oil price fuel a new rally in gold? In recent weeks, inflation fears and the associated concerns about rising interest rates have been among the key headwinds for precious metals. With the expected easing of geopolitical tensions in the Iran conflict, this pressure is now diminishing. Lower energy prices could ease inflation expectations, thereby reducing the likelihood of further rate hikes. Gold has recently defended the USD 4,000 per ounce level and even briefly traded above USD 4,300 on Wednesday. Gold expert Markus Bußler remains bullish, a view that should also support renewed strength in gold equities. Lahontan Gold is in an exciting phase. The company is currently transitioning from explorer to producer—not just anywhere, but in one of the world's most attractive gold mining regions. While preparations for mine construction are underway, the company continues to report positive drill results.

    Read

    Commented by André Will-Laudien on June 29th, 2026 | 07:10 CEST

    Gold, Defense, Aerospace: Sector Rotation in Full Swing – SpaceX, OHB, Desert Gold, Rheinmetall, and TKMS

    • Mining
    • Gold
    • Silver
    • Commodities
    • Africa
    • Defense
    • Steel
    • Space

    Stock markets remain surprisingly resilient as the end of June approaches, but the glossy surface is starting to fade in certain segments. The bull market in aerospace is losing steam, and in the defense sector, after many months of gains, profit-taking is now becoming noticeable. As a result, valuations are gradually re-aligning with fundamentals. For rational investors, market hype is difficult to reconcile with, but one thing remains clear: stocks that become excessively overvalued tend to correct sharply when expectations are pushed to extreme levels without sufficient justification. Just as with Elon Musk's inflated initial valuation, the exit bell has likely rung quite loudly for Rheinmetall as well. In the fall, analysts had been outbidding each other with price targets around EUR 2,200; now they are painfully backtracking. Price declines of 20% in just a few trading hours for the defence sector star, and a 30% drop from its peak for SpaceX. But there are other hot candidates worth a closer look. OHB is drawing attention following a significant capital increase, while TKMS has secured a major naval contract. These developments are actively reshaping market dynamics—we break down what it means in detail.

    Read